Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
This report studies the global market size of Spine Biologics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Spine Biologics in these regions.
This research report categorizes the global Spine Biologics market by top players/brands, region, type and end user. This report also studies the global Spine Biologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
North America region is the largest supplier of Spine Biologics, with a production market share nearly 63%. Europe is the second largest supplier of Spine Biologics, enjoying production market share nearly 28%.
North America is the largest consumption place, with a consumption market share nearly 61%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Market competition is not intense. Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. The Market Share of Medtronic is 40% in 2015.
With the development of medical technology level, more and more companies participate in this industry. For example, Spine Biologics of EnteroMedics and Inspire Medical have been approved by FDA in 2015.
The global Spine Biologics market is valued at 2060 million US$ in 2017 and will reach 2720 million US$ by the end of 2025, growing at a CAGR of 3.5% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Spine Biologics market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Market size by Product
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)
Market size by End User
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Spine Biologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Spine Biologics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Spine Biologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Spine Biologics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Spine Biologics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Spine Biologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
This research report categorizes the global Spine Biologics market by top players/brands, region, type and end user. This report also studies the global Spine Biologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
North America region is the largest supplier of Spine Biologics, with a production market share nearly 63%. Europe is the second largest supplier of Spine Biologics, enjoying production market share nearly 28%.
North America is the largest consumption place, with a consumption market share nearly 61%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Market competition is not intense. Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. The Market Share of Medtronic is 40% in 2015.
With the development of medical technology level, more and more companies participate in this industry. For example, Spine Biologics of EnteroMedics and Inspire Medical have been approved by FDA in 2015.
The global Spine Biologics market is valued at 2060 million US$ in 2017 and will reach 2720 million US$ by the end of 2025, growing at a CAGR of 3.5% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Spine Biologics market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Market size by Product
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)
Market size by End User
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Spine Biologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Spine Biologics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Spine Biologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Spine Biologics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Spine Biologics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Spine Biologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
